- Home
- AUDC vs CCCC Comparison
AUDC vs CCCC Comparison
Compare AUDC & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- CCCC
- Stock Information
- Founded
- AUDC 1992
- CCCC 2015
- Country
- AUDC Israel
- CCCC United States
- Employees
- AUDC N/A
- CCCC N/A
- Industry
- AUDC Telecommunications Equipment
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- AUDC Utilities
- CCCC Health Care
- Exchange
- AUDC Nasdaq
- CCCC Nasdaq
- Market Cap
- AUDC 266.8M
- CCCC 405.6M
- IPO Year
- AUDC 1999
- CCCC 2020
- Fundamental
- Price
- AUDC $9.69
- CCCC $6.25
- Analyst Decision
- AUDC Buy
- CCCC Buy
- Analyst Count
- AUDC 2
- CCCC 6
- Target Price
- AUDC $12.00
- CCCC $10.50
- AVG Volume (30 Days)
- AUDC 70.5K
- CCCC 731.1K
- Earning Date
- AUDC 11-06-2024
- CCCC 10-30-2024
- Dividend Yield
- AUDC 3.71%
- CCCC N/A
- EPS Growth
- AUDC 3.49
- CCCC N/A
- EPS
- AUDC 0.45
- CCCC N/A
- Revenue
- AUDC $245,529,000.00
- CCCC $29,378,000.00
- Revenue This Year
- AUDC $1.88
- CCCC $39.70
- Revenue Next Year
- AUDC $3.39
- CCCC N/A
- P/E Ratio
- AUDC $21.55
- CCCC N/A
- Revenue Growth
- AUDC N/A
- CCCC 83.26
- 52 Week Low
- AUDC $7.14
- CCCC $1.06
- 52 Week High
- AUDC $14.45
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- AUDC 51.91
- CCCC 54.57
- Support Level
- AUDC $9.42
- CCCC $6.26
- Resistance Level
- AUDC $9.99
- CCCC $7.14
- Average True Range (ATR)
- AUDC 0.21
- CCCC 0.37
- MACD
- AUDC 0.06
- CCCC 0.12
- Stochastic Oscillator
- AUDC 68.42
- CCCC 58.99
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.